Everest Medicines Limited (HKG:1952)
Hong Kong · Delayed Price · Currency is HKD 33.78
+0.02 (0.06%)
May 7, 2026, 4:08 PM HKT
Everest Medicines Employees
Everest Medicines had 812 employees as of December 31, 2025. The number of employees increased by 147 or 22.11% compared to the previous year.
Employees
812
Change (1Y)
147
Growth (1Y)
22.11%
Revenue / Employee
2.34M HKD
Profits / Employee
-408.08K HKD
Market Cap
11.86B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 812 | 147 | 22.11% |
| Dec 31, 2024 | 665 | 233 | 53.94% |
| Dec 31, 2023 | 432 | 67 | 18.36% |
| Dec 31, 2022 | 365 | -40 | -9.88% |
| Dec 31, 2021 | 405 | 256 | 171.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Shanghai Haohai Biological Technology | 2,110 |
| Ascentage Pharma Group International | 767 |
| Lepu Biopharma | 710 |
| Alphamab Oncology | 498 |
| CARsgen Therapeutics Holdings | 355 |
| HBM Holdings | 272 |
| Abbisko Cayman | 226 |
| Ascletis Pharma | 208 |
Everest Medicines News
- 4 weeks ago - China biotech flow picks up as Everest seals US$250 million deal - South China Morning Post
- 3 months ago - Everest Medicines Advances With Major Licensing Deal, New Drug Application Approval - Benzinga
- 3 months ago - Everest Medicines Transcript: 44th Annual J.P. Morgan Healthcare Conference - Transcripts
- 8 months ago - Everest Medicines Earnings Call Transcript: H1 2025 - Transcripts
- 1 year ago - Everest Medicines Earnings Call Transcript: H2 2024 - Transcripts
- 1 year ago - AI-powered Cancer Vaccine In The Works - Benzinga
- 1 year ago - Everest Medicines Transcript: Status Update - Transcripts
- 1 year ago - Everest Medicines Transcript: Study Update - Transcripts